HCV screening (n = 80) |
|
% clinic visits PCP able to screen at risk patients |
|
Never |
1 (1 %) |
<25 % |
30 (38 %) |
25–50 % |
12 (15 %) |
51–75 % |
15 (19 %) |
>75 % |
15 (19 %) |
Always |
7 (9 %) |
Report barriers to screening |
28 (35 %) |
Barriers identified (n = 28) |
|
Time constraints |
27 (96 %) |
Difficulty assessing if screened prior |
20 (71 %) |
Lack of resources/logistical support |
16 (57 %) |
Remaining current with guidelines |
10 (36 %) |
Concern about insurance coverage |
9 (32 %) |
Interventions that may improve screening (n = 80) |
|
EMR-based prompt |
77 (96 %) |
Support staff order screening test at check in |
59 (74 %) |
Additional patient education |
57 (71 %) |
Opt out screening in EMR |
41 (52 %) |
Report instances elect not to screen |
27 (34 %) |
Reasons not to screen (n = 27) |
|
Lack of time |
15 (56 %) |
Do not think patient will be treatment candidate |
10 (37 %) |
Reasons for referral (n = 80) |
|
Advanced disease (i.e., cirrhosis, end-stage liver disease) |
80 (100 %) |
Patient request |
79 (99 %) |
Determine if therapy indicated |
79 (99 %) |
Transplant consideration |
72 (90 %) |
Reasons would not refer (n = 80) |
|
Medical comorbidities |
18 (24 %) |
Psycho-social comorbidities/compliance |
16 (20 %) |
Lack of insurance |
15 (19 %) |